Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke
U Bayraktutan - Pharmacological Research, 2019 - Elsevier
Stroke is classified into two main groups depending on its aetiology; ischaemic stroke and
haemorrhagic stroke which successively develop from the occlusion or rupture of an artery …
haemorrhagic stroke which successively develop from the occlusion or rupture of an artery …
Endothelial progenitor cells biology in diabetes mellitus and peripheral arterial disease and their therapeutic potential
A Pyšná, R Bém, A Němcová, V Fejfarová… - Stem cell reviews and …, 2019 - Springer
Endothelial progenitors are a population of cells with the inherent capacity to differentiate
into mature endothelial cells and proangiogenic paracrine action. These characteristics …
into mature endothelial cells and proangiogenic paracrine action. These characteristics …
Bone marrow-derived cells restore functional integrity of the gut epithelial and vascular barriers in a model of diabetes and ACE2 deficiency
Rationale: There is incomplete knowledge of the impact of bone marrow cells on the gut
microbiome and gut barrier function. Objective: We postulated that diabetes mellitus and …
microbiome and gut barrier function. Objective: We postulated that diabetes mellitus and …
Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus
B Soria-Juan, N Escacena, V Capilla-González… - Frontiers in …, 2019 - frontiersin.org
Cell therapy is a progressively growing field that is rapidly moving from preclinical model
development to clinical application. Outcomes obtained from clinical trials reveal the …
development to clinical application. Outcomes obtained from clinical trials reveal the …
Peroxiredoxin6 in endothelial signaling
P Patel, S Chatterjee - Antioxidants, 2019 - mdpi.com
Peroxiredoxins (Prdx) are a ubiquitous family of highly conserved antioxidant enzymes with
a cysteine residue that participate in the reduction of peroxides. This family comprises …
a cysteine residue that participate in the reduction of peroxides. This family comprises …
Icariin reduces high glucose‑induced endothelial progenitor cell dysfunction via inhibiting the p38/CREB pathway and activating the Akt/eNOS/NO pathway
S Chen, Z Wang, H Zhou, B He… - Experimental and …, 2019 - spandidos-publications.com
High glucose (HG) impairs endothelial progenitor cell (EPC) function. The activation of p38
mitogen‑activated protein kinase and the inhibition of the Akt/eNOS/NO pathway serve …
mitogen‑activated protein kinase and the inhibition of the Akt/eNOS/NO pathway serve …
CD133+/C-kit+ Lin− endothelial progenitor cells in fetal circulation demonstrate impaired differentiation potency in severe preeclampsia
Y Park, HJ Lee, YJ Jung, HY Kwon, H Kim, JH Lee… - Pregnancy …, 2019 - Elsevier
Objectives Individuals delivered from preeclamptic pregnancies exhibit a long-term
increased risk of developing cardiovascular and metabolic diseases, likely caused by …
increased risk of developing cardiovascular and metabolic diseases, likely caused by …
Circulating progenitor cells and their interaction with platelets in patients with an acute coronary syndrome
PT Tatsidou, VG Chantzichristos, ME Tsoumani… - Platelets, 2019 - Taylor & Francis
Abstract CD34+ cells expressing KDR (CD34+/KDR+) represent a small proportion of
circulating progenitor cells that have the capacity to interact with platelets and to differentiate …
circulating progenitor cells that have the capacity to interact with platelets and to differentiate …
Patients with high levels of circulating endothelial progenitor cells (EPC) following at least three months of anticoagulation for unprovoked venous thromboembolism …
C Bradbury, T Buckley, YZ Sun, P Rose… - …, 2019 - thelancet.com
Background There is clinical need for a laboratory biomarker to identify patients who,
following an unprovoked venous thrombosis (VTE), are at low VTE recurrence risk and can …
following an unprovoked venous thrombosis (VTE), are at low VTE recurrence risk and can …
Effects of sitagliptin on the coronary flow reserve, circulating endothelial progenitor cells and stromal cell-derived factor-1alpha
T Morishita, H Uzui, H Ikeda, N Amaya, K Kaseno… - Internal …, 2019 - jstage.jst.go.jp
Objective Circulating endothelial progenitor cells (EPCs) are regulated by stromal cell-
derived factor-1alpha (SDF-1α) and are reduced in type 2 diabetes mellitus (DM). SDF-1α is …
derived factor-1alpha (SDF-1α) and are reduced in type 2 diabetes mellitus (DM). SDF-1α is …